Skip to main content

Prototype Prescribing Outlier Dashboard for Breightmet & Little Lever PCN

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all PCNs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given PCN is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all PCN's chemical:subparagraph ratios is provided, with this PCN's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Breightmet & Little Lever PCN is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Naphazoline hydrochloride 8 Other anti-inflammatory preparations 328 0.02 0.00 0.00 8.74
Promazine hydrochloride 1,773 Antipsychotic drugs 6,126 0.29 0.01 0.03 8.71
Levomepromazine maleate 219 Antipsychotic drugs 6,126 0.04 0.00 0.00 8.48
Nimodipine 8 Calcium-channel blockers 15,191 0.00 0.00 0.00 7.66
Enalapril maleate with diuretic 41 Angiotensin-converting enzyme inhibitors 14,902 0.00 0.00 0.00 6.08
Nebivolol 1,344 Beta-adrenoceptor blocking drugs 14,411 0.09 0.02 0.01 5.93
Alogliptin/metformin 517 Other antidiabetic drugs 7,029 0.07 0.00 0.01 5.92
Diethylamine salicylate 796 Rubefacients, topical NSAIDS, capsaicin and poultice 3,374 0.24 0.02 0.04 5.37
Betaine anhydrous 6 Drugs used in metabolic disorders 6 1.00 0.05 0.21 4.44
Torasemide 44 Loop diuretics 4,064 0.01 0.00 0.00 4.21

Prescribing where Breightmet & Little Lever PCN is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Gliclazide 1,627 Sulfonylureas 2,907 0.56 0.93 0.11 -3.32
Furosemide 2,719 Loop diuretics 4,064 0.67 0.85 0.07 -2.57
Bisoprolol fumarate 7,655 Beta-adrenoceptor blocking drugs 14,411 0.53 0.66 0.06 -2.24
Amitriptyline hydrochloride 4,874 Tricyclic and related antidepressant drugs 6,704 0.73 0.84 0.05 -2.12
Amlodipine 8,872 Calcium-channel blockers 15,191 0.58 0.75 0.08 -2.01
Ganciclovir 0 Antivirals 2 0.00 0.65 0.33 -2.00
    Carbamazepine 585 Control of epilepsy 13,967 0.04 0.07 0.02 -1.92
    Menthol 20 Topical local anaesthetics and antipruritics 149 0.13 0.47 0.17 -1.89
    Leflunomide 0 Rheumatic disease suppressant drugs 908 0.00 0.05 0.03 -1.73
      Glycopyrronium bromide 11 Antimuscarinic drugs 73 0.15 0.78 0.36 -1.73